Adastra Holdings Ltd.
XTXXF · OTCMCIK 1891512fmd_0C9F0B7QJTVMK81BTMBNNCCBYVManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Dec 31, 2022, 3 periods
| Line item | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
| Total revenues | 2 | 6 | 13 |
| Cost of revenue | 2 | 4 | 7 |
| Gross profit | 1 | 2 | 6 |
| Research and development | 0 | 0 | 0 |
| Operating income | (7) | (2) | (1) |
| Interest expense | 0 | 0 | 0 |
| Income before taxes | (8) | (3) | (4) |
| Income tax expense | 0 | (0) | (0) |
| Net income from continuing operations | (8) | (3) | (4) |
| Net income | (8) | (3) | (4) |